LHC Pharma

Our network

Specific partners, in specific places, doing specific work.

LHC's strength is its network. We do not operate as a faceless distributor, every country we serve, every shelf our products reach, traces back to a named partner with a real relationship. Below is the full list.

Strategic & equity partners

KRKA d.d.(Slovenia)

KRKA d.d. Novo Mesto is one of the top five generic pharmaceutical manufacturers in Europe, headquartered in Slovenia and operating across more than 70 countries worldwide. KRKA is a fully vertically integrated manufacturer of high-quality generics, with EU GMP-certified manufacturing facilities, a portfolio spanning cardiovascular, central nervous system, anti-infective, oncology, and metabolic products, and annual revenues exceeding EUR 2 billion. LHC holds an exclusive strategic partnership with KRKA across Southern Africa.

VS International(South Africa)

70+ SAHPRA-registered product lines transferred under marketing authorisation. The partnership underpins LHC's status as the holder of the largest Black-owned pharmaceutical portfolio in South Africa.

Macleods Limited(India)

One of India's leading HIV API and finished-formulation manufacturers. Primary supplier for LHC's 2026 NDoH Solid Dosage Tender.

Alveta(South Africa)

Multivitamin and nutritional supplement range distribution. Active in private market since LHC's commercial entry.

City Medical(South Africa)

Wholesale distribution listing secured 2025, providing additional commercial channel coverage in the South African private market.

CSIR(South Africa)

Joint development of an innovative recombinant HPV 16 & 18 vaccine for cervical cancer prevention. Clinical trials underway, a potential first-in-class South African vaccine.

Jiuyuan Gene(China)

Pegfilgrastim (NMPA-approved), Daratumumab (clinical trial permit), and Fulvestrant (NMPA-approved). NMPA is a full ICH member, qualifying these products for SAHPRA reliance-pathway registration.

Eva Pharma(Egypt)

Lenacapavir generic for HIV treatment and PrEP. Gilead's voluntary licensee, with SAHPRA pathway open. Submission planned 2026–2027.

Eris Lifesciences(India)

Sundae Semaglutide for diabetes and obesity treatment, CDSCO + ANVISA approved. Affordable semaglutide alternative for South Africa's 4.5M diabetes patients.

Channel partners

Dis-Chem

National retail pharmacy chain, significant presence across South Africa.

Clicks

National retail pharmacy chain, leading high-street footprint.

Medirite

Retail pharmacy chain.

Kalapeng Spar Pharmacies

Largest Black-owned pharmacy group in South Africa, operating within the Spar retail network.

Arrie Nel Pharmacies

Independent pharmacy group.

Want to join the network?

If you operate a pharmacy, wholesale operation, or distribution business in southern Africa and would like to discuss carrying LHC products, send us a note.

Open partnership form